Asset Management Ventures
  • ABOUT
  • OUR STORY
  • TEAM
  • PORTFOLIO
  • PERSPECTIVES
  • CONTACT
Select Page

Portfolio

  • All
  • Current
  • Digital Health
  • Life Sciences
  • Technology
  • Featured Historical
  • All
  • Home
1DocWay
3T Biosciences
Aavia
Aegis
Amgen
Amygdala Neurosciences
Applied Biosystems
AppliedMicro
Arterys
Audentes
Benefitter
Biogen Idec
BiPar Sciences
Cardiogen
Carta Healthcare
Chimerix
CV Therapeutics
D2G Oncology
Decent
Esperion Therapeutics
Evidation Health
Freenome
HealthTap
HuiSeoul
ICON Aircraft
ImmunoCellular Therapeutics
Incarda
Indi Molecular
KeepSafe
Kii
Lark
LiquidM
Mightier
Mozio
Nuance
Ooma
Outcomes4Me
Pharmacyclics
PMC-Sierra
Profusa
Properly
Provade
RallyPoint
Rapidscan
Reify
Secure AI Labs
SensOmics
SignalVine
Skybox Imaging
Stratavia
SubjectWell
Tandem Computers
Twist BioScience
Unikey
Unnatural Products
Viewpoint
Virtio
Welkin
WellDoc
Womply

AMV

AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

2595 E Bayshore Rd, Suite 240
Palo Alto, CA
650.621.8808

© 2019 Asset Management Ventures
All Rights Reserved